Optic pathway tumors are typically indolent, with most patients experiencing stable disease. Treatment decisions for these slow-growing tumors remain complex, balancing efficacy with potential side effects.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: